TMPRSS2 and COVID-19: Notably, since TMPRSS2 is highly expressed in lung cells, this may explain why the exclusive endosomal entry inhibitor hydroxychloroquine (HCQ) failed in treating COVID-19 patients [17,18,19,20,21].